Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 17–24 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
AbbVie Inc. Pivekimab sunirine (PVEK) Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) PDUFA Ongoing Intravenous Oncology
AbbVie Inc. trenibotulinumtoxinE (TrenibotE) Moderate to severe glabellar lines PDUFA Ongoing Intramuscular N/A
AbbVie Inc. Tavapadon - (TEMPO-2) Parkinson's disease PDUFA Ongoing Oral Neurology
AbbVie Inc. Tavapadon - (TEMPO-2) Parkinson's disease PDUFA Ongoing Oral Neurology
AbbVie Inc. trenibotulinumtoxinE (TrenibotE) Moderate to severe glabellar lines PDUFA Ongoing Intramuscular N/A
AbbVie Inc. Pivekimab sunirine (PVEK) Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) PDUFA Ongoing Intravenous Oncology
AbbVie Inc. telisotuzumab-vedotin (Teliso-V) Advanced/metastatic nonsquamous non-small cell lung cancer (NSCLC) BLA Filing Ongoing Intravenous Oncology
AbbVie Inc. VENCLEXTA (venetoclax) and acalabrutinib - (AMPLIFY) Chronic Lymphocytic Leukemia (CLL) sNDA Filing Ongoing Oral Oncology